Marijuana - Companies & Stocks

[BottomBounce]

$MJNA has Full Time Employees: 91

[BottomBounce]

$MJNA nice day today. Lots of buying activity

[fink]

If those con artist in Congress would get off their deadbeat asses and legalize this stuff.

I thought Democrats were in favor of big social issues? They got the power, do something!

Everything is a political football to them.

[BottomBounce]

$MJNA First to Introduce Medical Cannabis Products to Puerto Rico
In Sept. of 2015, Medical Marijuana, Inc. became the first company to have cannabis products approved for sale in the U.S. territory of Puerto Rico. This island of 3.6 million is a significant market for CBD hemp oil products like Real Scientific Hemp Oil™ (RSHO™). https://www.medicalmarijuanainc.com/company-of-firsts/the-first-to-create-medical-cannabis-products-to-puerto-rico/

[BottomBounce]

$MJNA Industrial Hemp Market Worth $15.26 Billion By 2027 | CAGR: 15.8% The global industrial hemp market size is expected to reach USD 15.26 billion by 2027,
https://grandviewresearch.com/press-release/global-industrial-hemp-market

[fink]

When America goes to Pot, will Pot lobbiest restrict American Pot to American grown Pot Companies only?


The boarders are not going to bust wide open?

This is why I dumped all my Canadian Pot plays.
Canada is over grown in supply.
America will too in a few short years of legal pot
It’s why I want in and out with a few 100%

[Hunchbackgeek]

AGRA/AGFAF AgraFlora International Company Website https://www.agraflora.com/

Quote:
AgraFlora’s flagship Canadian asset is Propagation Services Canada, a large-scale commercial greenhouse in Delta, BC, which is focused on reshaping the Canadian flower market with high-potency, low-cost cannabis. In addition, AgraFlora’s subsidiary, Farmako GmbH, is focused on becoming Europe’s leading distributor of medical cannabis.


.

[Hunchbackgeek]

AGRA is AGFAF in the US here's info: https://www.otcmarkets.com/stock/AGFAF/overview

[Hunchbackgeek]

Hi SpotOnTrade! Check out AGRA. Shares are cheap......

... right now and there some speculation that will change soon.

[BottomBounce]

$CVSI CV Sciences, Inc. is a life science company. The Company operates in two segments: specialty pharmaceuticals and consumer products. The Company's specialty pharma business segment is focused on developing and commercializing therapeutics utilizing synthetic Cannabidiol (CBD) across several therapeutic areas. The consumer product business segment is focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors.
Company Contact

Headquarters

10070 Barnes Canyon Rd
San Diego, CA 92121-2722

https://cvsciences.com/

[BottomBounce]

$MJNA First to Provide Access to Medical Cannabis Products in Paraguay
In May of 2016, Real Scientific Hemp Oil™ became the first medical cannabis product approved and imported for use in Paraguay. This event marked the third time in a little over a year that RSHO™ was the first cannabis product approved in a Latin American country, following the lead of Brazil and Mexico. https://www.medicalmarijuanainc.com/company-of-firsts/the-first-to-provide-access-to-medical-cannabis-products-in-paraguay/

[BottomBounce]

$MJNA First to Provide Access to Medical Cannabis Products in Paraguay
In May of 2016, Real Scientific Hemp Oil™ became the first medical cannabis product approved and imported for use in Paraguay. This event marked the third time in a little over a year that RSHO™ was the first cannabis product approved in a Latin American country, following the lead of Brazil and Mexico. https://www.medicalmarijuanainc.com/company-of-firsts/the-first-to-provide-access-to-medical-cannabis-products-in-paraguay/

[BottomBounce]

$MJNA First Company to have Cannabis Products Subsidized by Mexican Government
In August 2017, the State of Mexico became the first state in the country to subsidize CBD products for its citizens, agreeing to purchase THC-free Real Scientific Hemp Oil™-X (RSHO™-X) from MJNA international subsidiary HempMeds® Mexico for individuals suffering from a variety of serious indications. https://www.medicalmarijuanainc.com/company-of-firsts/first-company-cannabis-products-subsidized-mexican-government/

[fink]

$GRYN and it’s 7.2mm OTCQB float is making a move back to its $1.80 high.
Not sure what’s up, but it’s looking strong.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164340721

[Drugdoctor]

$SHWZ $2.55 Analyst VIDEO says-BUY-this-marijuana-stock-NOW!>>WATCH>>

[Hunchbackgeek]

..."the spark that reignites cannabis stocks?" https://www.cnn.com/2021/06/02/investing/premarket-stocks-trading/index.html

"Is Amazon the spark that reignites cannabis stocks?"


.

[Drugdoctor]

Wow- $SHWZ bought a Marijuana Farm today. Videos-and-pics>>
https://www.instagram.com/p/CAL4s8LBLYp/

[Drugdoctor]

$SHWZ$2.58 - The stock up sharply under heavy-accumulation after announcing stellar earnings May 13th and projecting $110 million revenues for 2021!

[Big Papa]

Planet 13 PLNHF will post earning afterhours on Thursday May 27th



Very interesting to see how Planet 13 earnings will play out on Thursday afterhours. We should see strong growth for the quarter and strong guidance for Q2. The Vegas strip is opening back up and the demand for Planet 13's product is soaring. They recently announced adding 40 more registers and 80 more employees to meet the demands. Also They will be opening their Santa Ana location July first bringing their brand to one of the largest Marijuana markets in the country. For anyone new to Planet 13 just picture Costco and Disneyland merging together in the marijuana industry

*112,000sqft dispensary largest in the World

*Recent news 10.7 million in sales for month of April

*Record single day sale of $540,000 on 04/20/2021

*Second location opening in Orange county California "Santa Anna" on July 1st 2021- 55,000sqft facility with over 16,500sqft dedicated to the dispensary

*Over 70 million in Revenue for 2020 and now on pace for over $100+ million for 2021

*181 million OS with a large portion held by insiders

[Alexulf]

Lexarias CBD Trial On Hypertension VERY Promising Tests News.

https://www.barchart.com/story/news/1656715/lexaria-bioscience-corp-discusses-potential-of-dehydratechtm-cbd-for-revolutionary-hypertension-solution-with-the-stock-day-podcast

"The hypertension market is obviously very large, it has been around a long time, and it is a mature market," explained Bunka before elaborating on the Company's competitors in this sector. "We're all using CBD, but in Lexaria's case, we have clinical data that evidence that with our DehydraTECH process CBD absorbs into the body two to five times more effectively," he explained.

Yesterday's News a Potential Catalyst Today.

[Drugdoctor]

$SHWZ$2.60-Colorado-Marijuana-Co-BLOWOUT-503%-REVENUE-increase-Q1-2021>>

[happyglass]

What do you folks think happens next in the US cannabis space with Biden basically flubbing rescheduling, taxation, and firing his own staff? Is this just too early in the game or should I shift away from US into other parts of the world that are actually interested in health and money?

[Drugdoctor]

$SHWZ$2.71-is-REDHOT! Today's chart shows VALUE coming into the shares, now that they have acquired and are operating 17 STARBUDS dispensaries in Colorado, and PurpleBees Manufacturing, and a grow. The stock is in a strong uptrend since last week's analyst OUTPERFORM rating and projected $110 million+ 2021 revenues, with POSITIVE earnings.

[Rich]

THE very FIRST marijuana board on iHub!!

[Drugdoctor]

Hmmm... $SHWZ is now up to $2.52 - Value coming into the shares after this amazing analyst report

[Drugdoctor]

$SHWZ$2.30+10% leading my Marijuana watchlist today. Schwazze has become a huge company and NET PROFITABLE.. Details>>

[Drugdoctor]

$SHWZ-NEW-INTERVIEW-with-CEO-JUSTIN-DYE on You-Tube by Joe-GOMES-Noble-ANALYST>>

[Drugdoctor]

Just-INCREDIBLE what Colorado-Marijuana-Co $SHWZ $2.20 has become>>>> only 43 million shares outstanding.

[Hunchbackgeek]

$OGI OrganiGram NEWS ~ https://finance.yahoo.com/news/organigram-acquires-thc-soft-chew-162257888.html


.

[BottomBounce]

$SNDL The global cannabis market is expected to reach US$ 153,689.9 Mn in 2027 from US$ 10,838.1 in 2018. https://www.businesswire.com/news/home/20191001005593/en/Global-150-Billion-Cannabis-Market-to-2027---ResearchAndMarkets.com

[Hunchbackgeek]

$AGRA~"AGM BUSINESS PRESENTATION MARCH/26/2021 CSE:AGRA FRANKFURT:PU31 OTC:AGFAF"......

https://agraflora.ca/wp-content/uploads/2021/03/AgraFlora-Post-AGM-Business-Update-Presentation-21-03-26.pdf

https://agraflora.ca/investors/

.

[Drugdoctor]

$SHWZ$2.02-reports-Marijuana-earnings-tomorrow!-$28-Million-NET-PROFITS-on-$70-Million-Revenues-is-noted-in-Article-Below. And they own 4 more dispensaries and a grow and a processing plant that are all PROFITABLE also.

With only 42.3 million outstanding shares... $SHWZ may be the next $2 to $20 runner in the Marijuana Sector, and there have been several that went PROFITABLE and have those kinds of gains in the past 6 months... GLTA

[Hunchbackgeek]

$OGI~"Organigram and BAT Form Product Development Collaboration – Includes Strategic Investment from BAT for 19.9% Equity Interest"

https://investors.organigram.ca/organigram-and-bat-form-product-development-collaboration-includes-strategic-investment-from-bat


.

[Drugdoctor]

$SHWZ$2.46-Now-owns-17-Colo.-USA-Dispensaries-GROW-MFR!-Most-Undervalued-Marijuana?>>

[BottomBounce]

$MJNA

[Guccimayne]

MNGG

[BottomBounce]

$SNDL After Election Results, Sundial Is Still a Legalization Lottery Ticket http://finance.yahoo.com/news/election-results-sundial-still-legalization-180952959.html

[BottomBounce]

$HEMP Industrial Hemp Market Worth $15.26 Billion By 2027 | CAGR: 15.8% The global industrial hemp market size is expected to reach USD 15.26 billion by 2027, exhibiting a revenue-based CAGR of 15.8% over the forecast period, according to a new report published by Grand View Research, Inc.
https://www.grandviewresearch.com/press-release/global-industrial-hemp-market

[mc67]

$SNDL Strategic Investment in Edibles Adds Value to Sundial Growers The Indiva stake only enhances the bull thesis for SNDL stock as the cannabis edibles category emerges By Louis Navellier - InvestorPlace Research Staff, Editor, Growth Investor 2-22-21 https://investorplace.com/2021/02/strategic-investment-in-edibles-adds-value-to-sndl-stock/

[dorismd2001]

$IDCN, CBD oil, is buying back shares in very large amounts.

https://www.reddit.com/r/IDCN/comments/lpm4di/updates_from_hq_idcn_feb_22_2021/

$IDCN will be a monster CBD player.
IDCN's hemp tested among the highest CBD levels in southern Wisconsin

https://twitter.com/IndocanInc

[mc67]

$SNDL Sundial Growers Inc. has 52 institutional owners and shareholders that have filed 13D/G or 13F forms with the SEC These institutions hold a total of 22,682,873 shares. Largest shareholders include Susquehanna International Group, Llp, Millennium https://fintel.io/so/us/sndl

[Alexulf]

PRESSRELEASE; TGOD Provides Statement On Subsidiary HemPoland!

https://www.barchart.com/story/stocks/quotes/TGODF/news/1127630/view

YESTERDAYS NEWS; See Partnership with Namaste

[Martinell]

Look into $OMID they already reported amazing yearly numbers for 2020.. next PR or quarterly report will send this stock flying

[Golden Cross]

VITX .032 Opening in USA
Vitana-X to Seek FDA Approval to Launch Products in the U.S.

Share this article now
Company Update:
https://www.accesswire.com/625966/Vitana-X-to-Seek-FDA-Approval-to-Launch-Products-in-the-US



Vitana-X Europe's revenue will be included in its quarterly results, which is due by February 28, 2021.
https://www.nasdaq.com/press-release/gh-capitals-vitana-x-closes-acquisition-of-its-licensee-in-europe-2020-12-21

[Hunchbackgeek]

Thanks, for the kind words HappyGlass:)

[happyglass]

You are an eye witness to history being made. You were on of the first to post the Hershey factory too were you not? I love your DD

[l2 hunter]

++ SLNX OO13 +8% Cannabis legazilation pending!!! Countdown for MJ stocks like SLNX .... on watch for possible multipler!! T/A + SS UPDATE OUT!! ONLY 1.3 BIL FLOAT!! FILINGS NEXT??? RADAR FOR POSSIBLE MULTIPLER


Ticker Buzz Cloud (24 hours)
Time Interval: 24hr | 12hr | 6hr | 3hr | 1hr
AABB ALST AMC APRU AVXL BIEL BRLL CCTL CEO CLSH COWI CYDY CZNI DPLS ENZC GME GPFT GSFI GTCH HCMC HPIL HWAL INKW INND IPIX MGON MINE MJLB NOW NWBO ONE OPTI PCTL PHIL PVDG RGGI RSI RUN SBFM SGTM SHMN SNDL SNVP SNWR SSET TPTW TSNP VITX VPER WDLF

[Alexulf]

Lexaria Outlook is Promising After Jazz Acquisition of GW
2021-02-09 08:31 ET - News Release
New York, New York--(Newsfile Corp. - February 9, 2021) - PCG Digital - Chris Bunka is a happy man. As CEO of Lexaria Bioscience (NASDAQ: LEXX) since 2006, he's battled to legitimize cannabinoids as a mainstream medical solution. This week, his dream is coming true. Jazz Pharmaceuticals, a major player with $2.3 billion in annual revenue, has entered the fray.
The deal went down on Wednesday, February 3rd. Jazz completed an acquisition of GW Pharmaceuticals, developers of Epidiolex, the first cannabinoid-based medical solution to be approved in the United States. GW reported $500 million in sales of the drug last year.

Epidiolex was approved in 2018 for the treatment of childhood-onset forms of epilepsy. Previous treatments for the condition had been inconsistent. Use of the drug has since been expanded to cover a wide range of seizure-related illnesses.
Portfolio managers for cannabis ETFs immediately weighed in on the deal. Dan Ahrens at AdvisorShares summed it up best. "Cannabinoid products are rapidly gaining acceptance in the public eye," he said. "The news is a surprise, but the opportunity and price are not."

Lexaria Stock Surges Following News Release
The entrance of mainstream pharma into the cannabis market has already created a ripple effect in the space. Lexaria (NASDAQ: LEXX) share prices rose 32% overnight, giving them a total net gain of 74.4% over the past five days, with an average daily volume of over 1mm shares traded.
Chris Bunka is not surprised. "We have an upcoming human clinical study focused on cannabinoids for hypertension and are exploring applications for central nervous system disorders," he explained. "The hypertension market is ten times larger than GW's seizure market. This can be massive for LEXX."
Lexaria has already received granted patents in the EU and Australia to use its technology to treat heart disease. The company effected a reverse stock split on its common stock in January, concurrent with an $11m capital raise, earning them a timely listing on NASDAQ.

LEXX opened at $7.60 on Thursday, up from their NASDAQ entrance price of $4.05 on January 12th. It was at $4.84 on February 2nd, so the majority of that growth has come since the Jazz/GW deal was announced. It's no surprise that company execs are smiling this morning.
Advanced Drug Delivery Technology with Lexaria DehydraTECH
With a current market cap under $50 million, on a comparative basis Lexaria appears to be undervalued. Their proprietary drug delivery technology, trademarked as DehydraTECH, is one of the main reasons why.
This disruptive technology was developed to improve the way that active pharmaceutical ingredients enter the bloodstream. It can be applied to drugs and vitamins to increase absorption rates and deliver more powerful dosages in a smaller time frame.

Lexaria is employing the use of DehydraTECH to develop cannabinoid medical solutions and safer nicotine consumption products, but it can also be applied to consumer-packaged goods and most products that come in capsule, pill, tablet, or topical application form.
The technology is available to be licensed by manufacturers. According to Lexaria's website, there are companies with operations in over one hundred countries examining DehydraTECH for possible use to more effectively deliver their products.

Lexaria CBD DehydraTECH Hypertension Studies
Beginning with an early human clinical study in 2018, Lexaria has been researching the effects of their patented DehydraTECH oral capsule on hypertension and the resulting heart disease that inevitably follows that condition. A confirmatory second human clinical study completed design last Fall and is expected to begin the dosing phase in upcoming months.
Both studies focused on showing evidence of lowered blood pressure, higher blood flow to the brain, and faster and more effective delivery onset of CBD into the bloodstream. The 2018 version utilized a 90mg dosage of DehydraTECH processed CBD which did lower blood pressure, whereas an equal dose of generic CBD did not. The 2021 study is a human trial with a 300mg dosage.
"Positive results in the new study are expected to be of particular interest to the antihypertensive products sector, which is valued at over $22 billion," stated CEO Chris Bunka. "According to the CDC, hypertension affects over one billion people worldwide."
The results of the study, should they prove to be positive, could accelerate the uptrend in Lexaria share prices. According to Chris Bunka, positive results will "strengthen the company's value proposition pursuant to its intention to seek out pharmaceutical industry partners."

Lexaria's Commitment to the Treatment of COVID-19
Lexaria believes that it is possible to use DehydraTECH technology to facilitate an oral application of anti-viral drugs currently being administered by injection. This group includes medications for HIV, hepatitis, influenza, and coronavirus.
They're not referring to vaccines. Forty-eight million people were infected with COVID-19 during the pandemic of 2020. Many of them will have long-term health issues resulting from their exposure, even if symptoms are no longer visibly apparent.
According to the company's researchers, "Vaccines help prevent the transmission of viral diseases. They don't actually treat symptoms and are only effective 50% to 80% of the time. Anti-viral drugs will always be needed to treat people who become infected."
This is good news for a world where the fallout from COVID-19 is still uncertain. It's great news for investors eyeing Lexaria as a money-making opportunity in 2021. The antiviral drug market is currently estimated at $52 billion and expected to top $75 billion by 2027.

Disclaimer:
This communication was produced by PCG Digital Holdings, LLC, an affiliate of PCG Advisory Inc., (together "PCG". PCG is an integrated investor relations, communications and strategic advisory firm. The information contained on this may be 'Paid Advertising' for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the "Securities Act". PCG may be compensated by respective clients for publicizing information relating to its client's securities. For more information in terms of compensation received for services provided by PCG, see the pertinent advertising materials relating to the respective client. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy.

[Drugdoctor]

$SHWZ now $3.19!!! Here's the amazing chart>>>






And UPDATE to the NEWS below... They just added 2 more STARBUDS!!

[Golden Cross]

$VITX Vitana Award Winning Patented Technology Products...

Vitana-X has awesome products and technology that I believe all should begin to learn about:

https://vitanax.com/en/



Vitana IMMUNE-X




Vitana-X Launches REVIVAL as its Official Lifestyle Drink
https://vitanax.net/en/gh-capitals-vitana-x-launches-revival-as-its-official-lifestyle-drink/

https://finance.yahoo.com/news/gh-capitals-vitana-x-launches-123000129.html


https://finance.yahoo.com/news/gh-capitals-vitana-x-launches-123000129.html

Vitana-X BCAA (Branched-chain amino acids) energy drinks are boldly entering an extremely competitive and lucrative market with a fresh and innovative approach, as the life-promoting, healthy and natural alternative to the current leading chemical-based energy drinks.

BCAA are called leucine, isoleucine and valine. They are called essential amino acids because humans must ingest them through food to survive. BCAAs are necessary for the preservation of body tissue. Studoes have shown that they cause glycogen stores to remain full in the tissues. BCAAs also prevent the breakdown of muscle tissue during exercise.

Unlike other amino acids, BCAAs are not metabolized in the stomach but directly in the muscle. They are especially important during training and other sporting activities as they prevent muscle breakdown and support tissue regeneration.

Full spectrum of vitamins, minerals, trace minerals and ultratrace minerals.
No preservatives.
No sugar.
No fat.
No aspartame.

Complete with vitamin B12, B6, D, C, Zinc and Magnesium.

REVIVAL's message is a clear declaration of war on an unmanageable market that is flooded with countless energy and sports drinks - and obviously has little to do with health and real fitness. "It's about time we delivered something in the lifestyle segment that we know today thanks to new research and great technology," stated Matthias Goeth, assessing the market situation.

REVIVAL is available in three different varieties and flavors initially targeting the German market.

https://www.vital-durch-dna.com/



-------------------------------------------------------------------

https://vitanax.com/wissenschaft/
Increase in bioavailability to at least 95%

The bioavailability of poorly soluble and fat-soluble substances is very low and is usually below 20%. In everyday life, this means that when taking vitamin E, for example, often 80% or more of this valuable vitamin cannot be utilized. Most of the active ingredients are excreted unused and, in the worst case, still burden the organism. In addition, with increasing age, the body's ability to absorb fat-soluble substances decreases.

Using the technical term “micelle formation”, we are now able to convert poorly and fat-soluble substances into a water-soluble form. This solves the problem of low uptake. VITANA X in cooperation with a European laboratory has now succeeded in further improving this long-standing, tried and tested method. The result is an improved purity as well as a proven bioavailability of 95% (or more).

The so-called “encapsulated” state of the molecules results in high thermal, mechanical, sensory and microbiological stability. It is now also guaranteed that the substance (vitamin) ingested passes through the gastrointestinal passage without being destroyed or changed by the gastric acid. The effect of this water-soluble dosage form has been scientifically proven with studies and now enables a much better result in absorption.